Published in Medical Letter on the CDC and FDA, February 18th, 2007
Already approved for use throughout the European Union, the Synchrony system is being studied in a multicenter trial in the U.S. to evaluate safety and effectiveness and the potential for near and intermediate vision without the use of spectacles in patients post cataract surgery.
The proprietary Synchrony system, intended for use in cataract and refractive patients, incorporates a dual optic lens with an pre-loaded injector. The entire...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.